nach oben

Neuroradiology

Erschienen in:

01.10.2009 | Diagnostic Neuroradiology

Radiation dose from multidetector row CT imaging for acute stroke

verfasst von: Anisa Mnyusiwalla, Richard I. Aviv, Sean P. Symons

Erschienen in: Neuroradiology | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The objective of this study was to determine the radiation dose delivered during comprehensive computed tomography (CT) imaging for acute stroke.

Methods

All CT examinations performed over 18 months using our acute stroke protocol were included. Protocol includes an unenhanced CT head, CT angiography from the arch to vertex, CT perfusion/permeability, and an enhanced CT head. All imaging was acquired with a 64-MDCT. Examinations where any element of the protocol was repeated or omitted due to mistimed injection or patient motion were excluded. Dose-length products (DLP) for all components of each examination were obtained from dose reports generated at the time of acquisition, separating neck, and head calculations. Effective doses for each examination were calculated using the DLP and normalized values of effective dose per DLP appropriate for the body regions imaged.

Results

Ninety-five examinations were included. Mean DLP was 6,790.0 mGy·cm. Effective doses ranged from 11.8 to 27.3 mSv, mean effective dose of 16.4 mSv. Mean effective dose for acquisition of the unenhanced head was 2.7 mSv. Largest contribution to effective dose was the CTA with a mean effective dose of 5.4 mSv. Mean effective dose for the CT perfusion was 4.9 mSv.

Conclusion

A comprehensive CT acute stroke protocol delivered a mean effective dose of 16.4 mSv, which is approximately six times the dose of an unenhanced CT head. These high-dose results must be balanced with the benefits of the detailed anatomic and physiologic data obtained. Centers should implement aggressive dose reduction strategies and freely use MR as a substitute.

O’Rourke F, Dean N, Akhtar N, Shuaib A (2004) Current and future concepts in stroke prevention. CMAJ 170:1123–1133PubMed

Statistics Canada (1997) Selected leading causes of death by sex. Statistics Canada, Ottawa

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587CrossRef

del Zoppo GJ, Higashida RT, Furlan AJ et al (1998) PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 29:4–11PubMed

Furlan A, Higashida R, Wechsler L et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282:2003–2011PubMedCrossRef

Mullins ME, Schaefer PW, Sorensen AG et al (2002) CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology 224:353–360PubMedCrossRef

Lovblad KO, Laubach HJ, Baird AE et al (1998) Clinical experience with diffusion-weighted MR in patients with acute stroke. Am J Neuroradiol 19:1061–1066PubMed

Baird AE, Lovblad KO, Dashe JF et al (2000) Clinical correlations of diffusion and perfusion lesion volumes in acute ischemic stroke. Cerebrovasc Dis 10:441–448PubMedCrossRef

Singer OC, Sitzer M, du Mesnil de Rochemont R, Neumann-Haefelinl T (2004) Practical limitations of acute stroke MRI due to patient-related problems. Neurology 62:1848–1849PubMed

10.

Wintermark M, Meuli R, Browaeys P et al (2007) Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology 68:694–697PubMedCrossRef

11.

Miles KA (2004) Brain Perfusion: computed tomography applications. Neuroradiology 46(Suppl 2):S194–S200PubMedCrossRef

12.

Aviv RI, d’Esterre C, Murphy B et al (2009) Relationship between CT perfusion derived blood-brain barrier permeability surface area product and hemorrhagic transformation of ischemic stroke. Radiology 250:867–877PubMedCrossRef

13.

Huda W, Ogden KM, Khorasani MR (2008) Converting dose-length product to effective dose at CT. Radiology 248:995–1003PubMedCrossRef

14.

Jessen KA, Shrimpton PC, Geleijns J et al (1999) Dosimetry for optimization of patient protection in computed tomography. Appl Radiat Isot 50:165–172PubMedCrossRef

15.

Katz SI, Saluja S, Brink JA, Forman HP (2006) Radiation dose associated with unenhanced CT for suspected renal colic: impact of repetitive studies. Am J Roentgenol 186:1120–1124CrossRef

16.

Horiguchi J, Kiguchi M, Fujioka C et al (2008) Radiation dose, image quality, stenosis measurement, and CT densitometry using ECG-triggered coronary 64-MDCT angiography: a phantom study. Am J Roentgenol 190:315–320CrossRef

17.

Cohnen M, Wittsack HJ, Assadi S et al (2006) Radiation exposure of patients in comprehensive computed tomography of the head in acute stroke. Am J Neuroradiol 27:1741–1745PubMed

18.

Imanishi Y, Fukui A, Niimi H et al (2005) Radiation-induced temporary hair loss as a radiation damage only occurring in patients who had combination of MDCT and DSA. Eur Radiol 15:41–46PubMedCrossRef

19.

Pierce DA, Preston DL (2000) Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res 154:178–186PubMedCrossRef

20.

Cardis E, Vrijheid M, Blettner M et al (2007) The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Radiat Res 167:396–416PubMedCrossRef

21.

National Council on Radiation Protection and Measurements (1993) Limitation of exposure to ionizing radiation. NUCRP report 116. National Council on Radiation Protection and Measurements, Bethesda

22.

Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council (2006) Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2. National Academies, Washington, DC

23.

Shrimpton PC, Hillier MC, Lewis MA et al (2006) National survey of doses from CT in the UK: 2003. Br J Radiol 79:968–980PubMedCrossRef

24.

Hall EJ, Giaccia AJ (2006) Radiation cataractogenisis. In Radiobiology for the radiologist, 6th edn. Lippincott Williams Williams, Philadelphia

25.

Neriishi K, Nakashima E, Minamoto A et al (2007) Postoperative cataract cases among atomic bomb survivors: radiation dose response and threshold. Radiation Research 168:404–408PubMedCrossRef

26.

Wintermark M, Maeder P, Verdun FR et al (2000) Using 80 kVp versus 120 kVp in perfusion CT measurement of regional cerebral blood flow. Am J Neuroradiol 21:1881–1884PubMed

27.

Hirata M, Murase K, Sugawara Y et al (2005) A method for reducing radiation dose in cerebral CT perfusion study with variable scan schedule. Radiat Med 23:162–169PubMed

28.

Smith AB, Dillon WP, Lau BC et al (2008) Radiation dose reduction strategy for CT protocols: successful implementation in neuroradiology section. Radiology 247:499–506PubMedCrossRef

29.

Ederies A, Demchuk A, Chia T et al (2009) Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients. Stroke 40(5):1672–1676PubMedCrossRef

30.

Smith AB, Dillon WP, Gould R et al (2007) Radiation dose-reduction strategies for Neuroradiology CT protocols. Am J Neuroradiol 28:1628–1632PubMedCrossRef

Titel: Radiation dose from multidetector row CT imaging for acute stroke
verfasst von: Anisa Mnyusiwalla
Richard I. Aviv
Sean P. Symons
Publikationsdatum: 01.10.2009
Verlag: Springer-Verlag
Erschienen in: Neuroradiology / Ausgabe 10/2009
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI: https://doi.org/10.1007/s00234-009-0543-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2009

Perfusion differences on SPECT and PWI in patients with acute ischemic stroke

Endovascular transplantation of stem cells to the injured rat CNS

Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter

18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen

European Society of Neuroradiology (ESNR)